378 related articles for article (PubMed ID: 29534151)
1. A novel computational approach for drug repurposing using systems biology.
Peyvandipour A; Saberian N; Shafi A; Donato M; Draghici S
Bioinformatics; 2018 Aug; 34(16):2817-2825. PubMed ID: 29534151
[TBL] [Abstract][Full Text] [Related]
2. DRviaSPCN: a software package for drug repurposing in cancer via a subpathway crosstalk network.
Wu J; Li X; Wang Q; Han J
Bioinformatics; 2022 Oct; 38(21):4975-4977. PubMed ID: 36066432
[TBL] [Abstract][Full Text] [Related]
3. A new computational drug repurposing method using established disease-drug pair knowledge.
Saberian N; Peyvandipour A; Donato M; Ansari S; Draghici S
Bioinformatics; 2019 Oct; 35(19):3672-3678. PubMed ID: 30840053
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
Wang Y; Yella J; Jegga AG
Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
[TBL] [Abstract][Full Text] [Related]
5. Drug repurposing against breast cancer by integrating drug-exposure expression profiles and drug-drug links based on graph neural network.
Cui C; Ding X; Wang D; Chen L; Xiao F; Xu T; Zheng M; Luo X; Jiang H; Chen K
Bioinformatics; 2021 Sep; 37(18):2930-2937. PubMed ID: 33739367
[TBL] [Abstract][Full Text] [Related]
6. A network-based drug repurposing method via non-negative matrix factorization.
Sadeghi S; Lu J; Ngom A
Bioinformatics; 2022 Feb; 38(5):1369-1377. PubMed ID: 34875000
[TBL] [Abstract][Full Text] [Related]
7. Pan-transcriptome-based candidate therapeutic discovery for idiopathic pulmonary fibrosis.
Wang Y; Yella JK; Ghandikota S; Cherukuri TC; Ediga HH; Madala SK; Jegga AG
Ther Adv Respir Dis; 2020; 14():1753466620971143. PubMed ID: 33167785
[TBL] [Abstract][Full Text] [Related]
8. Computationally repurposing drugs for breast cancer subtypes using a network-based approach.
Firoozbakht F; Rezaeian I; Rueda L; Ngom A
BMC Bioinformatics; 2022 Apr; 23(1):143. PubMed ID: 35443626
[TBL] [Abstract][Full Text] [Related]
9. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
Mottini C; Napolitano F; Li Z; Gao X; Cardone L
Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
[TBL] [Abstract][Full Text] [Related]
10. gene2drug: a computational tool for pathway-based rational drug repositioning.
Napolitano F; Carrella D; Mandriani B; Pisonero-Vaquero S; Sirci F; Medina DL; Brunetti-Pierri N; di Bernardo D
Bioinformatics; 2018 May; 34(9):1498-1505. PubMed ID: 29236977
[TBL] [Abstract][Full Text] [Related]
11. Computational biology approaches for drug repurposing.
Waseem T; Rajput TA; Mushtaq MS; Babar MM; Rajadas J
Prog Mol Biol Transl Sci; 2024; 205():91-109. PubMed ID: 38789189
[TBL] [Abstract][Full Text] [Related]
12. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
[TBL] [Abstract][Full Text] [Related]
13. Drug repurposing: a promising tool to accelerate the drug discovery process.
Parvathaneni V; Kulkarni NS; Muth A; Gupta V
Drug Discov Today; 2019 Oct; 24(10):2076-2085. PubMed ID: 31238113
[TBL] [Abstract][Full Text] [Related]
14. NMSDR: Drug repurposing approach based on transcriptome data and network module similarity.
Ünsal Ü; Cüvitoğlu A; Turhan K; Işık Z
Mol Inform; 2023 Mar; 42(3):e2200077. PubMed ID: 36411244
[TBL] [Abstract][Full Text] [Related]
15. System biology approaches for drug repurposing.
Israr J; Alam S; Kumar A
Prog Mol Biol Transl Sci; 2024; 205():221-245. PubMed ID: 38789180
[TBL] [Abstract][Full Text] [Related]
16. Screening novel drug candidates for Alzheimer's disease by an integrated network and transcriptome analysis.
Peng Y; Yuan M; Xin J; Liu X; Wang J
Bioinformatics; 2020 Nov; 36(17):4626-4632. PubMed ID: 32516365
[TBL] [Abstract][Full Text] [Related]
17. Breaking the paradigm: Dr Insight empowers signature-free, enhanced drug repurposing.
Chan J; Wang X; Turner JA; Baldwin NE; Gu J
Bioinformatics; 2019 Aug; 35(16):2818-2826. PubMed ID: 30624606
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
Turanli B; Gulfidan G; Arga KY
OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
[TBL] [Abstract][Full Text] [Related]
19. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
20. A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer.
Chen HR; Sherr DH; Hu Z; DeLisi C
BMC Med Genomics; 2016 Jul; 9(1):51. PubMed ID: 27475327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
